Medicare Drug Negotiation Guidance: What You Need to Know
This week our In Focus section reviews the Centers for Medicare and Medicaid Services’ (CMS) announcement of initial guidance for the new Medicare Drug Price Negotiation Program for 2026.
Every Wednesday, HMA publishes the Weekly Roundup, an information-packed resource that will keep you updated on industry news, trends in state health policy throughout the nation, and more.
